We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Elevated Cytokine Levels Linked to Future Development of Myocardial Infarction

By LabMedica International staff writers
Posted on 17 May 2021
Elevated levels of the plasma biomarkers interleukin-6 (IL-6) and the IL-6 binary complex have been linked to the increased risk of myocardial infarction (MI) found in smokers and individuals with hypertension.

IL-6 acts as both a pro-inflammatory cytokine and an anti-inflammatory myokine. More...
It is secreted by macrophages in response to specific microbial molecules, referred to as pathogen-associated molecular patterns (PAMPs). These PAMPs bind to an important group of detection molecules of the innate immune system, called pattern recognition receptors (PRRs), including Toll-like receptors (TLRs). These are present on the cell surface and intracellular compartments and induce intracellular signaling cascades that give rise to inflammatory cytokine production. IL-6 is an important mediator of fever and of the acute phase response. The importance of IL-6 trans-signaling associated with risk of future myocardial infarction has not been studied to any great extent. Furthermore, whether elevation in IL-6 explains part of the association between traditional risk factors and future MI has not been explored.

In this regard, investigators at Örebro University (Sweden) sought to evaluate the association of plasma concentrations of IL-6 and IL-6 binary complex with the potential for future development of MI. IL-6 binary complex is a novel biomarker estimated from plasma concentration of IL-6, sIL-6R (soluble IL-6 receptor), and sgp130 (soluble-glycoprotein130) that reflects the extent of systemic IL-6 trans-signaling.

For this study, the investigators conducted a nested case-control study including a total of 584 participants (292 cases and 292 controls). At baseline, plasma cholesterol levels were measured, and clinical characteristics of participants were collected. The investigators measured the plasma concentration of IL-6, sIL-6R, and sgp130 and estimated the concentration of the IL-6 binary complex.

Results revealed that IL-6 binary complex concentration was significantly elevated in participants who experienced MI compared with those who did not. Furthermore, exposure to traditional cardiovascular disease risk factors contributed to elevated concentration of IL-6 binary complex. Univariate analyses showed that a 10-fold increase in IL-6 binary complex was associated with a 3.6 times higher risk of future MI. In addition, the investigators found a statistically significant indirect effect of smoking and hypertension on future MI that was mediated through increased IL-6 binary complex or plasma IL-6.

"What is unique about this study is that we have only studied the inflammatory aspects of IL-6. We have measured the levels of inflammatory IL-6 in the blood," said senior author Dr. Liza Ljungberg, senior lecturer in medical sciences at Örebro University. "Focusing on solely reducing the inflammatory characteristics of IL-6 could reduce inflammation without other important functions in the body being impaired. This means that serious side effects of the medication can be avoided."

The link between IL-6 and MI was discussed in the April 2021 issue of the journal Atherosclerosis, Thrombosis and Vascular Biology.

Related Links:
Örebro University


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.